August 14, 2019
Regeneron posts positive results from testing Evinacumab in patients with certain type of high cholesterol
Regeneron Pharmaceuticals on Wednesday said it got positive pivotal Phase 3 results for evinacumab, an investigational angiopoietin-like 3 (ANGPTL3) antibody, in patients with homozygous familial hypercholesterolemia (HoFH).